OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
Songyu Shen, Yihan Hong, Jiajun Huang, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 16-28
Closed Access | Times Cited: 4
Songyu Shen, Yihan Hong, Jiajun Huang, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 16-28
Closed Access | Times Cited: 4
Showing 4 citing articles:
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
Wei Xia, Yuanhao Lv, Yan Zou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Wei Xia, Yuanhao Lv, Yan Zou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
HVEM as a Tumor-Intrinsic Regulator in Non-Small Cell Lung Cancer: Suppression of Metastasis via Glycolysis Inhibition and Modulation of Macrophage Polarization
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8 + T Cells
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
Zhenjun Huang, Qing Peng, Luhui Mao, et al.
MedComm – Future Medicine (2025) Vol. 4, Iss. 1
Open Access
Zhenjun Huang, Qing Peng, Luhui Mao, et al.
MedComm – Future Medicine (2025) Vol. 4, Iss. 1
Open Access
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: remodulate tumor immune microenvironment and activate immune system
Lu Chen, Jie Yin, Ke Xu, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104717-104717
Closed Access
Lu Chen, Jie Yin, Ke Xu, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104717-104717
Closed Access
